Work ability before and after sarcoidosis diagnosis in Sweden

被引:29
作者
Arkema, Elizabeth V. [1 ]
Eklund, Anders [2 ,3 ]
Grunewald, Johan [2 ,3 ]
Bruze, Gustaf [1 ]
机构
[1] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, S-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Med Solna Theme Inflammat & Infect, Stockholm, Sweden
[3] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Sarcoidosis; Disability; Economics; Epidemiology; AUTOIMMUNE-DISEASES; CARE; REGISTER; PATTERNS; GENDER; COSTS;
D O I
10.1016/j.rmed.2018.09.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Information on how sarcoidosis affects one's ability to work is needed to clarify the burden of disease on the individual and society. Our aim was to describe the work ability of individuals with sarcoidosis before and after diagnosis compared to people without sarcoidosis. Methods: Swedish national registers were used to identify adults diagnosed with sarcoidosis aged 25-59 years old and matched general population comparators without sarcoidosis 2006-2012. Information on work loss (days of sick leave and disability pension) and earnings (gross salary) was collected from the Longitudinal Integration Database for Health Insurance and Labor Market Studies. Mean earnings and work loss days per year from 5 years before to 5 years after diagnosis were calculated. Results: During diagnosis year, sarcoidosis patients (n = 3347) earned 8% less and registered 26 more work loss days than comparators (n = 33,407). The number of work loss days was higher than the general population in the years leading up to sarcoidosis diagnosis. Five years after diagnosis, the number of total work loss days decreased among sarcoidosis patients, but remained higher than that of the general population. Individuals who were older, female, less educated and received treatment at diagnosis registered the highest number of work loss days and had the largest difference in earnings at all time points. Conclusions: Individuals with sarcoidosis experience a reduction in work ability which persists for up to five years after diagnosis. Interventions targeted at getting sarcoidosis patients back to work should be evaluated.
引用
收藏
页码:S7 / S12
页数:6
相关论文
共 16 条
[1]  
[Anonymous], 2017, SOCIAL INSURANCE FIG
[2]   Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden [J].
Arkema, Elizabeth V. ;
Grunewald, Johan ;
Kullberg, Susanna ;
Eklund, Anders ;
Askling, Johan .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (06) :1690-1699
[3]   Sarcoidosis and Cancer Risk Systematic Review and Meta-analysis of Observational Studies [J].
Bonifazi, Martina ;
Bravi, Francesca ;
Gasparini, Stefano ;
La Vecchia, Carlo ;
Gabrielli, Armando ;
Wells, Athol U. ;
Renzoni, Elisabetta A. .
CHEST, 2015, 147 (03) :778-791
[4]  
Brito-Zerón P, 2016, CLIN EXP RHEUMATOL, V34, P380
[5]   Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? [J].
Eriksson, Jonas K. ;
Johansson, Kari ;
Askling, Johan ;
Neovius, Martin .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (04) :648-654
[6]   Work Disability Before and After Diabetes Diagnosis: A Nationwide Population-Based Register Study in Sweden [J].
Ervasti, Jenni ;
Virtanen, Marianna ;
Pentti, Jaana ;
Lallukka, Tea ;
Tinghog, Petter ;
Kjeldgard, Linnea ;
Mittendorfer-Rutz, Ellenor ;
Alexanderson, Kristina .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (06) :E22-E29
[7]   Disease Burden and Variability in Sarcoidosis [J].
Gerke, Alicia K. ;
Judson, Marc A. ;
Cozier, Yvette C. ;
Culver, Daniel A. ;
Koth, Laura L. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 :S421-S428
[8]  
Gerke AK, 2014, SARCOIDOSIS VASC DIF, V31, P256
[9]   Lofgren's Syndrome Human Leukocyte Antigen Strongly Influences the Disease Course [J].
Grunewald, Johan ;
Eklund, Anders .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (04) :307-312
[10]   The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland [J].
Kawalec, Pawel P. ;
Malinowski, Krzysztof P. .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (04) :667-673